Tag: bioequivalence studies

Bioequivalence Studies: What FDA Requires Manufacturers to Prove

Posted On February 22, 2026 10

The FDA requires generic drug manufacturers to prove bioequivalence through strict pharmacokinetic studies, ensuring their products match the brand-name drug in absorption and effectiveness. This process ensures safety, efficacy, and cost savings for patients.

Crossover Trial Design: How Bioequivalence Studies Are Structured

Posted On December 15, 2025 15

Crossover trial design is the gold standard for bioequivalence studies, using each participant as their own control to compare generic and brand-name drugs efficiently. Learn how it works, when to use replicate designs, and what regulators require.